Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This is a study to confirm the superior efficacy of GSK1358820 over placebo in patients with
equinus deformity associated with post-stroke lower limb spasticity using the Modified
Ashworth Scale (MAS) ankle score.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA